Revealing the impact of gut microbiota-derived metabolites on depression through network pharmacology

A total of 208 metabolites and 223 targets were initially extracted from the gutMGene v1.0 database. In addition, 1,630 and 1,321 targets were identified using the Similarity Ensemble Approach and Swiss Target Prediction databases, respectively, resulting in 921 overlapping targets. By integrating d...

Full description

Saved in:
Bibliographic Details
Main Authors: Si Su, Tengarile A, Ruhan A, Riga Wu, Lisi Wei, La Ta, Wenfeng Huo, Lijun Tong, Jing Zhang, Rilebagen Hu, Li Li
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Artificial Cells, Nanomedicine, and Biotechnology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/21691401.2025.2531752
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850077924513808384
author Si Su
Tengarile A
Ruhan A
Riga Wu
Lisi Wei
La Ta
Wenfeng Huo
Lijun Tong
Jing Zhang
Rilebagen Hu
Li Li
author_facet Si Su
Tengarile A
Ruhan A
Riga Wu
Lisi Wei
La Ta
Wenfeng Huo
Lijun Tong
Jing Zhang
Rilebagen Hu
Li Li
author_sort Si Su
collection DOAJ
description A total of 208 metabolites and 223 targets were initially extracted from the gutMGene v1.0 database. In addition, 1,630 and 1,321 targets were identified using the Similarity Ensemble Approach and Swiss Target Prediction databases, respectively, resulting in 921 overlapping targets. By integrating data from gutMGenev1.0, 13 core targets were finally identified. A microbiota–metabolite–target–signal pathway–disease network was constructed using Cytoscape 3.9.1, revealing 15 metabolites associated with the IL-17, TLR, and PI3K-Akt signalling pathways. Among these, five metabolites exhibited favourable drug similarity and acceptable toxicological profiles. Molecular docking confirmed the stable binding of two key metabolites—succinate and phenylacetylglutamine—to their respective targets. The results showed that succinate and phenylacetylglutamine demonstrated strong binding affinities to IL-1β and GSK3B, both involved in the IL-17, TLR, and PI3K-Akt signalling pathways. IL-17 and TLR4, as important pro-inflammatory cytokines, are closely associated with the development of depression, while the PI3K/AKT signalling pathway plays a key role in its pathogenesis. The present study reveals the potential mechanisms by which gut microbiota influence MDD and provides a scientific basis and a comprehensive research framework for future investigations.
format Article
id doaj-art-0f34693a8fb04b4fbe1ff5659491f863
institution DOAJ
issn 2169-1401
2169-141X
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Artificial Cells, Nanomedicine, and Biotechnology
spelling doaj-art-0f34693a8fb04b4fbe1ff5659491f8632025-08-20T02:45:42ZengTaylor & Francis GroupArtificial Cells, Nanomedicine, and Biotechnology2169-14012169-141X2025-12-0153132734210.1080/21691401.2025.2531752Revealing the impact of gut microbiota-derived metabolites on depression through network pharmacologySi Su0Tengarile A1Ruhan A2Riga Wu3Lisi Wei4La Ta5Wenfeng Huo6Lijun Tong7Jing Zhang8Rilebagen Hu9Li Li10Faculty of Mongolian Medicine, Inner Mongolia Medical University, Hohhot, Inner Mongolia, ChinaFaculty of Mongolian Medicine, Inner Mongolia Medical University, Hohhot, Inner Mongolia, ChinaFaculty of Mongolian Medicine, Inner Mongolia Medical University, Hohhot, Inner Mongolia, ChinaFaculty of Mongolian Medicine, Inner Mongolia Medical University, Hohhot, Inner Mongolia, ChinaFaculty of Mongolian Medicine, Inner Mongolia Medical University, Hohhot, Inner Mongolia, ChinaFaculty of Mongolian Medicine, Inner Mongolia Medical University, Hohhot, Inner Mongolia, ChinaFaculty of Mongolian Medicine, Inner Mongolia Medical University, Hohhot, Inner Mongolia, ChinaFaculty of Mongolian Medicine, Inner Mongolia Medical University, Hohhot, Inner Mongolia, ChinaBasic Medical Faculty, Inner Mongolia Medical University, Hohhot, Inner Mongolia, ChinaFaculty of Mongolian Medicine, Inner Mongolia Medical University, Hohhot, Inner Mongolia, ChinaBasic Medical Faculty, Inner Mongolia Medical University, Hohhot, Inner Mongolia, ChinaA total of 208 metabolites and 223 targets were initially extracted from the gutMGene v1.0 database. In addition, 1,630 and 1,321 targets were identified using the Similarity Ensemble Approach and Swiss Target Prediction databases, respectively, resulting in 921 overlapping targets. By integrating data from gutMGenev1.0, 13 core targets were finally identified. A microbiota–metabolite–target–signal pathway–disease network was constructed using Cytoscape 3.9.1, revealing 15 metabolites associated with the IL-17, TLR, and PI3K-Akt signalling pathways. Among these, five metabolites exhibited favourable drug similarity and acceptable toxicological profiles. Molecular docking confirmed the stable binding of two key metabolites—succinate and phenylacetylglutamine—to their respective targets. The results showed that succinate and phenylacetylglutamine demonstrated strong binding affinities to IL-1β and GSK3B, both involved in the IL-17, TLR, and PI3K-Akt signalling pathways. IL-17 and TLR4, as important pro-inflammatory cytokines, are closely associated with the development of depression, while the PI3K/AKT signalling pathway plays a key role in its pathogenesis. The present study reveals the potential mechanisms by which gut microbiota influence MDD and provides a scientific basis and a comprehensive research framework for future investigations.https://www.tandfonline.com/doi/10.1080/21691401.2025.2531752Major depressive disorder (MDD)network pharmacologyprevotellaceaelachnospiraceaesuccinatephenylacetylglutamine
spellingShingle Si Su
Tengarile A
Ruhan A
Riga Wu
Lisi Wei
La Ta
Wenfeng Huo
Lijun Tong
Jing Zhang
Rilebagen Hu
Li Li
Revealing the impact of gut microbiota-derived metabolites on depression through network pharmacology
Artificial Cells, Nanomedicine, and Biotechnology
Major depressive disorder (MDD)
network pharmacology
prevotellaceae
lachnospiraceae
succinate
phenylacetylglutamine
title Revealing the impact of gut microbiota-derived metabolites on depression through network pharmacology
title_full Revealing the impact of gut microbiota-derived metabolites on depression through network pharmacology
title_fullStr Revealing the impact of gut microbiota-derived metabolites on depression through network pharmacology
title_full_unstemmed Revealing the impact of gut microbiota-derived metabolites on depression through network pharmacology
title_short Revealing the impact of gut microbiota-derived metabolites on depression through network pharmacology
title_sort revealing the impact of gut microbiota derived metabolites on depression through network pharmacology
topic Major depressive disorder (MDD)
network pharmacology
prevotellaceae
lachnospiraceae
succinate
phenylacetylglutamine
url https://www.tandfonline.com/doi/10.1080/21691401.2025.2531752
work_keys_str_mv AT sisu revealingtheimpactofgutmicrobiotaderivedmetabolitesondepressionthroughnetworkpharmacology
AT tengarilea revealingtheimpactofgutmicrobiotaderivedmetabolitesondepressionthroughnetworkpharmacology
AT ruhana revealingtheimpactofgutmicrobiotaderivedmetabolitesondepressionthroughnetworkpharmacology
AT rigawu revealingtheimpactofgutmicrobiotaderivedmetabolitesondepressionthroughnetworkpharmacology
AT lisiwei revealingtheimpactofgutmicrobiotaderivedmetabolitesondepressionthroughnetworkpharmacology
AT lata revealingtheimpactofgutmicrobiotaderivedmetabolitesondepressionthroughnetworkpharmacology
AT wenfenghuo revealingtheimpactofgutmicrobiotaderivedmetabolitesondepressionthroughnetworkpharmacology
AT lijuntong revealingtheimpactofgutmicrobiotaderivedmetabolitesondepressionthroughnetworkpharmacology
AT jingzhang revealingtheimpactofgutmicrobiotaderivedmetabolitesondepressionthroughnetworkpharmacology
AT rilebagenhu revealingtheimpactofgutmicrobiotaderivedmetabolitesondepressionthroughnetworkpharmacology
AT lili revealingtheimpactofgutmicrobiotaderivedmetabolitesondepressionthroughnetworkpharmacology